Sensiotec
Sensiotec Inc. is a development stage company based in Atlanta, Georgia, focused on commercializing next-generation wireless medical monitoring devices that improve healthcare quality and safety while reducing costs. They have developed the Preventa(TM) device, which is the world’s first ultra-wideband (UWB) non-contact, continuous monitor for vital signs and movement, capable of remote monitoring and alerting caregivers to health crises, thereby enhancing disease management and reducing healthcare costs.
Industries
Nr. of Employees
small (1-50)
Sensiotec
Products
Non-contact ultra-wideband vital-signs and movement monitoring device
A continuous, remote monitoring device that uses ultra-wideband radar sensing to detect heart and respiration rates, bed occupancy, and patient movement; includes asset-tracking and patient-location functions and integration for automated access-control actions to protect wandering patients.
Non-contact ultra-wideband vital-signs and movement monitoring device
A continuous, remote monitoring device that uses ultra-wideband radar sensing to detect heart and respiration rates, bed occupancy, and patient movement; includes asset-tracking and patient-location functions and integration for automated access-control actions to protect wandering patients.
Expertise Areas
- Remote patient monitoring
- Non-contact radar-based vital-sign detection
- Ultra-wideband (UWB) wireless medical devices
- Regulatory submissions for Class II medical devices (FDA 510(k))
Key Technologies
- Ultra-wideband (UWB) radar sensing
- Non-contact vital-sign detection
- Wireless telemetry and remote monitoring platforms
- Real-time signal processing and alerting
News & Updates
Sensiotec Inc. announced FDA 510(k) Class II clearance for the world's first ultra-wideband (UWB) non-contact, continuous monitor for heart and respiration rates, bed occupancy, and movement, under the brand name Preventa(TM). The device enables remote, real-time monitoring of patients, helping to reduce complications, optimize resources, and contain healthcare costs.
Sensiotec Inc. announced FDA 510(k) Class II clearance for the world's first ultra-wideband (UWB) non-contact, continuous monitor for heart and respiration rates, bed occupancy, and movement, under the brand name Preventa(TM). The device enables remote, real-time monitoring of patients, helping to reduce complications, optimize resources, and contain healthcare costs.